Document is current
Any future updates will be listed below
-
Authors
Yehia, Lamis
Li, Lin
Idumah, Gideon
Frazier, Thomas W.
Makarov, Vladimir
Bose, Aritra
Parida, Laxmi
Hardan, Antonio
Martinez-Agosto, Julian A.
Ritter, David M.
Sahin, Mustafa
Eng, Charis
Ni, Ying
,
Busch, Robyn
Currans, Kristn D.
Dies, Kira
Filip-Dhima, Rajna
Gulsrud, Amanda
Hanson, Ellen
Kent, Bridget
Klaas, Patricia
Phillips, Jennifer M.
-
Funding
Funding for this research was provided by:
American Cancer Society
Ambrose Monell Foundation
Doris Duke Charitable Foundation
National Center for Advancing Translational Sciences
Breast Cancer Research Foundation
National Institute of Child Health and Human Development
- License Information
-
More Information
Article History
Received: 5 November 2025
Accepted: 17 February 2026
First Online: 17 March 2026
Competing interests
: T.W.F. has received funding or research support from, acted as a consultant to, received travel support from, and/or received a speaker’s honorarium from the PTEN Research Foundation, SYNGAP Research Fund, Malan Syndrome Foundation, ADNP Kids Research Foundation, Quadrant Biosciences, Autism Speaks, Impel NeuroPharma, F. Hoffmann-La Roche AG Pharmaceuticals, the Cole Family Research Fund, Simons Foundation, Ingalls Foundation, Forest Laboratories, Ecoeos, IntegraGen, Kugona LLC, Shire Development, Bristol-Myers Squibb, Roche Pharma, MaraBio, Scioto Biosciences, Linus Biotechnology, National Institutes of Health, and the Brain and Behavior Research Foundation, has equity options in Quadrant Biosciences/Autism Analytica, MaraBio, has an investor stake in Autism EYES LLC, is employed by CentralReach, and is a co-owner of iSCAN-R and AI-Measures. C.E. was an Associate Editor for npj Genomic Medicine but played no role in the peer-review or decision to publish this manuscript. All other authors declare no competing financial or non-financial interests.
